PCMEMED Stock Latest News
Private CompaniesMeMed Study Links Host-Response Testing to Lower Antibiotic Use and Admissions1d agoMEMED
Private CompaniesMeMed Highlights Hospital Use Case for Sepsis Diagnostic Workflow6d agoMEMED
Private CompaniesFDA Clearance Expands U.S. Access to MeMedBV Assay2w agoMEMED
Private CompaniesReal‑World Urgent Care Data Bolster MeMed BV Diagnostic Value Proposition2w agoMEMED
Private CompaniesClinical Study Signals Potential Economic and Outcome Benefits for MeMed BV Diagnostic3w agoMEMED
Private CompaniesClinical Study Spotlight on MeMed’s Host-Protein Diagnostic at IDWeek 20263w agoMEMEDPrivate CompaniesMeMed Highlights Growing Evidence and Partnerships in Emergency Care Diagnostics1M agoMEMED
Private CompaniesDesign Award Highlights Progress in MeMed’s Point-of-Care Diagnostics1M agoMEMED
Private CompaniesMeMed Highlights New Sepsis Evidence Brochure for MeMed BV1M agoMEMED
Private CompaniesMeMed Sepsis Test Adopted by Tampa General Hospital Emergency Department1M agoMEMED
Private CompaniesTampa General Integrates MeMed BV Sepsis Test Into Emergency Care Workflow1M agoMEMED
Private CompaniesMeMed BV Assay Added to American Proficiency Institute Program2M agoMEMEDPrivate CompaniesClinical Case Spotlight Highlights MeMed BV’s Role in Emergency Infection Management2M agoMEMED
Private CompaniesMeMed Highlights Role of Infection Differentiation in Sepsis Care Pathways2M agoMEMED
Private CompaniesMeMed Diagnostic Cited in UK Analysis on Sepsis Care and Cost Savings3M agoMEMED
Private CompaniesDiagnostic Adoption in NHS Setting Underscores MeMed’s Infection Management Focus3M agoMEMED
Private CompaniesMeMed Aligns Sepsis Diagnostics With NHS England Framework Priorities3M agoMEMED
Private CompaniesMeMed Targets Wider Hospital Adoption With Host-Response Diagnostics Push at ADLM 20263M agoMEMEDPrivate CompaniesMeMed Highlights Host-Response Diagnostics and MeMed BV Evidence at ADLM 20263M agoMEMED

